ResMed Denmark A/S: Financial statements 2025
CVR: 30699246
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
ResMed Denmark A/S (CVR 30699246) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 27,103,584 and a net result of DKK 7,641,198 compared with DKK 5,923,165 the year before. That is an increase of 23.2% compared with the year before. Equity in the 2025 report amounted to DKK 42,043,276. The solvency ratio was 71%.
- Gross Profit
- DKK 27,103,584
- Profit/Loss
- DKK 7,641,198
- Equity
- DKK 42,043,276
- Total Assets
- DKK 59,248,551
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 27.1M | 7.6M | 42M | 0 |
| 2024 | - | 22M | 5.9M | 34.4M | 20 |
| 2023 | - | 22M | 5.8M | 28.5M | 19 |
| 2022 | - | 18.2M | 3.8M | 22.7M | 18 |
| 2021 | - | 15.5M | 3.4M | 18.8M | 16 |
Official annual report
How creditworthy is ResMed Denmark A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of June 25, 2025, is registered as an owner of ResMed Denmark A/S with an ownership share of 100%.
ResMed Denmark A/S has won the tender "Udbud på Udstyr til behandling af patienter med søvnapnø samt udstyr til NIV-behandling til primært hjemmepatienter" issued by Region Sjælland worth 42,447,482 DKK.
About ResMed Denmark A/S
ResMed Denmark A/S is a Danish company of the type Aktieselskab based in Maribo, founded in 2007. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ResMed Maribo A/S and MARIBO MEDICO A/S. The management consists of Malene Brun Petersen. The board consists of Michael James Rider (chair), Jussi Antero Vuorela, Malene Brun Petersen and Nigel Wayne Robinson. The company is owned by ResMed Sensor Technologies Ltd. The company has 22 employees (2026). In 2026, the company reported a gross profit of DKK 27,805,765 and a net result of DKK 8,090,129 compared with DKK 7,641,198 the year before. Equity in the 2026 report amounted to DKK 50,133,405.